Disclaimer :
This Product Image is the Property of Arvantis Pharmaceuticals. Using this Product Image Without Prior Permission is Prohibited and Ignoring this Request May Lead to Legal Consequences.
Composition
Metformin Hydrochloride Sustained Release Tablets IP
Description
METARV SR (Metformin Hydrochloride Sustained Release Tablets IP) is an oral antidiabetic medicine used for the effective management of Type 2 diabetes mellitus. Its sustained-release formulation helps provide prolonged blood glucose control by improving insulin sensitivity, reducing glucose production in the liver, and enhancing glucose utilization. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable tablets with consistent therapeutic performance. These tablets are ideal for PCD Pharma Franchise, third-party manufacturing, hospital supply, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat
Tablets
Capsules
Softgels
Syrups & Susp.
Injectables
Drops
Cream-lotions
Dry Syrups
Others
